Health
Common Antibiotic May Reduce Schizophrenia Risk in Teenagers, Study Suggests
A widely used antibiotic could play a surprising role in lowering the risk of schizophrenia among young people, according to new research published in the American Journal of Psychiatry.
The study found that teenagers who were prescribed doxycycline, a common antibiotic used to treat infections and acne, were 30 to 35 percent less likely to develop schizophrenia in adulthood than those treated with other antibiotics. Researchers described the findings as “tentative but exciting,” emphasising that while the results are promising, more research is needed to confirm them.
Schizophrenia affects around 23 million people globally and typically develops in early adulthood. The condition is characterised by hallucinations, delusional thinking, and cognitive difficulties, which can significantly disrupt daily life. While medication and therapy can help manage symptoms, there is currently no cure.
The Finnish study examined health records from more than 56,000 adolescents who had received mental health treatment. Of these, about 16,000 were prescribed doxycycline. The results showed a notable difference in schizophrenia diagnoses later in life, suggesting that the antibiotic might offer some level of protection.
Although the study was observational and cannot prove that doxycycline directly prevents schizophrenia, researchers believe the link may be tied to how the drug reduces inflammation in the brain. Doxycycline is known to have anti-inflammatory properties, and inflammation has been increasingly linked to psychiatric disorders.
The team also pointed to another possible mechanism: synaptic pruning. This is a natural process in which the brain eliminates unnecessary neurons and synapses during adolescence. When pruning occurs abnormally, it has been associated with schizophrenia. The researchers suggest doxycycline may influence this process in a beneficial way.
“This is an important signal to further investigate the protective effect of doxycycline and other anti-inflammatory treatments in adolescent psychiatry patients,” said Ian Kelleher, the study’s lead author and a professor of child and adolescent psychiatry at the University of Edinburgh. He added that the approach “could potentially reduce the risk of developing severe mental illness in adulthood.”
However, experts not involved in the study urged caution. Dominic Oliver, a psychiatry researcher at the University of Oxford, noted that “many other treatments have shown early promise and have ultimately shown not to be effective in large-scale trials.”
Dr Katharina Schmack, a psychosis researcher at The Francis Crick Institute in London, said that while the findings were statistically significant, “the absolute numbers are modest.” She explained that after doxycycline treatment, instead of five out of 100 people developing schizophrenia, the figure would drop to about two or three.
Both experts agreed that the research opens a valuable avenue for further investigation into how inflammation and brain development affect schizophrenia risk. As Schmack put it, “Uncovering clinical associations in studies like this is important because this can direct further biological investigations.”
-
Entertainment2 years agoMeta Acquires Tilda Swinton VR Doc ‘Impulse: Playing With Reality’
-
Business2 years agoSaudi Arabia’s Model for Sustainable Aviation Practices
-
Business2 years agoRecent Developments in Small Business Taxes
-
Sports2 years agoChina’s Historic Olympic Victory Sparks National Pride Amid Controversy
-
Home Improvement1 year agoEffective Drain Cleaning: A Key to a Healthy Plumbing System
-
Politics2 years agoWho was Ebrahim Raisi and his status in Iranian Politics?
-
Sports2 years agoKeely Hodgkinson Wins Britain’s First Athletics Gold at Paris Olympics in 800m
-
Business2 years agoCarrectly: Revolutionizing Car Care in Chicago
